Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activity in middle ear effusions.

J M Bernstein, H A Schenkein, R J Genco

    Clinical and Experimental Immunology
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anticardiolipin from Periodontitis Patients Impact Fetal Loss and Annexin V.

    Journal of dental research·2020
    Same author

    Human Glanders.

    The Hospital·2018
    Same author

    Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer.

    Advances in dental research·2014
    Same author

    Anticardiolipin in porphyromonas gingivalis antisera causes fetal loss in mice.

    Journal of dental research·2013
    Same author

    Rhabdomyosarcoma of the trachea: first reported case treated with proton beam therapy.

    The Journal of laryngology and otology·2012
    Same author

    Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2012
    Same journal

    Helios expression in naïve CD4+ T cells decreases from neonates to older adults.

    Clinical and experimental immunology·2026
    Same journal

    Could we discuss the molecular signature of immune dysregulation?

    Clinical and experimental immunology·2026
    Same journal

    The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

    Clinical and experimental immunology·2026
    Same journal

    PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

    Clinical and experimental immunology·2026
    Same journal

    Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

    Clinical and experimental immunology·2026
    Same journal

    Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

    Clinical and experimental immunology·2026
    See all related articles

    This study investigated complement system activation in middle ear fluids of otitis media patients. Findings show complement components are utilized and inactivated, suggesting a role in the condition.

    Area of Science:

    • Immunology
    • Otolaryngology
    • Biochemistry

    Background:

    • Otitis media with effusion (OME) is a common condition characterized by fluid accumulation in the middle ear.
    • The role of the complement system, a crucial part of innate immunity, in the pathogenesis of OME is not fully understood.

    Purpose of the Study:

    • To investigate evidence of complement system activation and utilization within middle ear fluids (MEF) from patients diagnosed with OME.
    • To identify specific complement components and their cleavage products present in MEF.

    Main Methods:

    • Immunochemical analysis was employed to detect complement cleavage products (C3, C4, Factor B) in MEF.
    • Protein concentrations in MEF were compared to serum concentrations.
    • Hemolytic assays were performed to assess the activity of early complement components (C1-C5).

    Related Experiment Videos

    Main Results:

    • Cleavage products of C3, C4, and Factor B were immunochemically detected in MEF, indicating complement activation.
    • Native C3 was found at significantly lower concentrations in MEF compared to other proteins, relative to serum levels.
    • Hemolytic assays demonstrated inactivation of early complement components (C1-C5) in MEF.

    Conclusions:

    • The presence of complement cleavage products and the inactivation of early components strongly suggest complement utilization within the middle ear during OME.
    • These findings imply that the complement system may play a significant role in the inflammatory processes associated with OME.
    • Further research into the specific mechanisms of complement activation and its consequences in MEF is warranted.